cGAS-STING-mediated DNA sensing maintains CD8⁺ T cell stemness and promotes antitumor T cell therapy

Area of Science:

• Immunology
• Cancer Biology
• Molecular Biology

Background:

• The cGAS-STING pathway is vital for detecting DNA and initiating immune responses against tumors.
• Its role in T cells, particularly CD8+ T cells, and its impact on cancer immunotherapy remain largely unexplored.

Purpose of the Study:

• To investigate the function of the intrinsic cGAS-STING pathway in CD8+ T cells.
• To determine the potential of targeting this pathway to improve T cell-based cancer immunotherapy.

Main Methods:

• Analysis of cGAS-STING cascade expression in CD8+ T cells from cancer patients.
• Assessment of the role of cGAS-STING in adoptively transferred CD8+ T cells in mouse models.
• Investigation of the mechanistic link between cGAS-STING, TCF1, and Akt signaling in T cell maintenance and differentiation.
• Evaluation of STING agonism in enhancing T cell function and CAR-T cell therapy in a xenograft model.

Main Results:

• CD8+ T cells from cancer patients exhibit reduced cGAS-STING expression.
• The cGAS-STING pathway is essential for effective antitumor immune responses in T cell therapy.
• cGAS-STING signaling promotes stem cell-like CD8+ T cell maintenance by regulating TCF1 and restraining Akt activity.
• STING activation boosts stem-like memory CD8+ T cell formation and enhances CAR-T cell therapy efficacy in preclinical models.

Conclusions:

• Intrinsic cGAS-STING activation in T cells is critical for antitumor immunity and T cell therapy success.
• Targeting the cGAS-STING pathway offers a promising strategy for augmenting T cell-based cancer immunotherapies.